Atalan
PrivateLast Round
Seed
Oct 5, 2023
Est. Valuation
$5.5M
Total Funding Raised
$2.5M
Company Overview
Atalan is a healthcare technology company that provides a Clinician Retention Intelligence (CRI) platform, using machine learning to help health systems predict and prevent clinician resignations.
Sector
Enterprise Software
Verticals
Vertical SaaS, Healthcare Analytics, Medical AI, HR
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Atalan Comps
Public and private peers based on sector, stage, and business model.
Atalan Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 5, 2023 |
Key People
Founding team and executive leadership
Atalan Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Early Light Ventures | Seed |
| Excelerate Health Ventures | Seed |
| XLerateHealth | Seed |
| OCA Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
New nursing-focused product set to launch in Q1 2026.
- Dec 10, 2025
Launched Atalan PX, an AI module, with Accrete Health Partners.
Atalan Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Atalan's valuation, stock price, and market status.
